What is ONC's relative strength rating?

ONC ranks at the 78th percentile over 1 month, 81th percentile over 3 months, 47th percentile over 6 months, 61th percentile over 1 year against the full TickerStance CS+ADRC universe of U.S. equities.

What sector is ONC in?

ONC is classified under the Healthcare sector within the Pharmaceutical Products industry per the TickerStance sector-classification pipeline, which maps U.S. equities to GICS-aligned sectors using exchange SIC codes and Massive Finance reference data. Healthcare is currently ranked 3 of 11 sectors by relative strength.

Is ONC in a leading sector?

Yes — Healthcare ranks at the 82th percentile by sector relative strength, placing it in the leading band (≥ 70th percentile). ONC benefits from positive sector-level momentum, which historically correlates with above-average stock-level RS performance in the O'Neil / Minervini framework.

ONC currently shows a 20-day average daily range (ADR%) of 2.3%, a 90-day beta versus the S&P 500 of 0.60. ADR% and ATR% are updated daily; beta is computed over a trailing 90-day window.

Does ONC have a seasonal pattern?

TickerStance computes ONC's month-by-month seasonality from its full daily price history: the average and median return for each calendar month, how often that month closed higher, and the best and worst months on record. These are historical frequencies, not forecasts — a strong seasonal month describes what ONC has tended to do in prior years, not a prediction of what comes next. The full month-by-month heatmap and win-rate table sit higher on this page.

When did ONC last report earnings?

ONC most recently filed a 10-Q covering FY26 Q2 with the SEC on 2026-08-05. TickerStance sources earnings data from SEC EDGAR XBRL submissions and updates the fundamentals panel daily. The Pro dossier shows eight quarters of EPS and revenue trend, operating margin history, and a composite earnings-quality rank.

BeOne Medicines Ltd. American Depositary Shares (ONC)

TODAY'S READ · AS OF 2026-08-24

As of 2026-08-24, BeOne Medicines Ltd. American Depositary Shares (ONC) has a 3-month relative strength percentile of 81 within the TickerStance CS+ADRC universe (~5,000 tickers). Its Power rating (absolute 1–99) is 53. The current market Stance is 47.8 (Neutral). Sector: Healthcare, ranked 3 of 11. Average daily range 2.3%, relative volume 0.88×. TickerStance reports observed regime conditions across the full CS+ADRC universe; band assignment reflects current breadth, momentum, and macro inputs computed at the daily close. Percentile ranks run from 1 (weakest) to 99 (strongest) relative to all universe members on the same date.

RS methodology →

Market-wide RS; lit = leaderboard

Lenses lit

3 month81pctile

6 month47pctile

1 year61pctile

Classic60IBD pctile

LDR85leadership

0 of 5 lenses lit · avg RS pctile 67

!ADR%2.3%✓A/DA!RVOL0.88×✓$ Vol$121M

Market backdrop

47.8Neutral

Trend30% weight44.9 Breadth30% weight50.6 Leadership20% weight42.4 Macro20% weight59.0 Full stance breakdown →

§ Seasonality

10y · since 2025

Best monthJul on averageavg +17.64% · 100% win · n 2

Worst monthDec on averageavg -10.80% · 0% win · n 1

ONC monthly seasonality strip
	Jan	Feb	Mar	Apr	May	Jun	Jul	Aug	Sep	Oct	Nov	Dec
1	ONC Jan avg: 17.16% median: 17.16% win: 100% σ: 7.24% n: 2 2025-01-03 → 2026-07-31	ONC Feb avg: 6.97% median: 6.97% win: 50% σ: 19.57% n: 2 2025-01-03 → 2026-07-31	ONC Mar avg: -3.09% median: -3.09% win: 50% σ: 4.56% n: 2 2025-01-03 → 2026-07-31	ONC Apr avg: -2.56% median: -2.56% win: 0% σ: 2.81% n: 2 2025-01-03 → 2026-07-31	ONC May avg: -3.98% median: -3.98% win: 0% σ: 2.11% n: 2 2025-01-03 → 2026-07-31	ONC Jun avg: -1.23% median: -1.23% win: 0% σ: 0.29% n: 2 2025-01-03 → 2026-07-31	ONC Jul avg: 17.64% median: 17.64% win: 100% σ: 9.55% n: 2 2025-01-03 → 2026-07-31	ONC Aug avg: 1.63% median: 1.63% win: 100% σ: 0.00% n: 1 2025-01-03 → 2026-07-31 (current)	ONC Sep avg: 11.32% median: 11.32% win: 100% σ: 0.00% n: 1 2025-01-03 → 2026-07-31	ONC Oct avg: -8.87% median: -8.87% win: 0% σ: 0.00% n: 1 2025-01-03 → 2026-07-31	ONC Nov avg: 9.70% median: 9.70% win: 100% σ: 0.00% n: 1 2025-01-03 → 2026-07-31	ONC Dec avg: -10.80% median: -10.80% win: 0% σ: 0.00% n: 1 2025-01-03 → 2026-07-31

Evidence · 1 of 3

Receipts behind the read

2 of 5 pass

Leadership

Is it leading?

Relative strength across horizons plus the leadership score.

1m

78

3m

81

6m

47

1y

61

LDR

—

StageWeinstein stage analysis

Stage 1 · Basing

Smart money

Who's accumulating?

Accumulation rating, relative volume, U/D ratio, breakout-day proof.

Fundamentals · ONC

Does the business back the chart?

SEC EDGAR · last filing 10-Q · FY26 Q2 · period end 2026-06-30

94

Fundamentals Growth Rank

How does growth rank vs. the universe?

vs. 4,480 ranked stocks · Sector rank 94

View fundamental leadership map

Leader

Earnings

Is earnings accelerating?

Diluted EPS, last 8 quarters. Positive EPS uses YoY change.

Triple-digit

−$0.09—

24 Q3

−$0.10—

24 Q4

Evidence · 2 of 3

Sector context

Healthcare · 82th pctile in sector

Top peers · Healthcare

Who else is leading?

ELOX
99RS 3m
FBRX
99RS 3m
MRNA
99RS 3m
ONC
81RS 3m · you

Sector vs market

Healthcare · 3 of 11

Energy100

Technology91

Healthcare82

Financials

PEERS · Pharmaceutical Products

Same industry, closest relative strength

4 peers · by RS6M

GNLXGenelux Corporation Common Stock47 NKTRNektar Therapeutics46 SRPTSarepta Therapeutics,, Inc. Common Stock46 PTCTPTC Therapeutics, Inc.47

ETF OWNERS

ETFs holding ONC

ONC is held by 12 ETFs as of May 2026. Top owner: CGGE at 0.55% weight, $15M notional. Top 3 carry $32M.

Held by 28 ETFs · $297M across latest filings · largest weight 3.25% (BBH).

ETFs holding: 12
Total value: $45M
Top 3 concentration: 69.5%
Max weight: AGNG · 2.24%

Top 10 by value, from SEC N-PORT-P filings dated May 2026.

ETFs holding ONC ranked by value
ETF	Weight	Value	Δ
CGGE	0.55%	$15M	−0.10 pp
CGIE	0.50%	$11M	+0.02 pp
CGNG	0.21%	$5M	−0.05 pp
CANC	1.88%	$3M	+0.10 pp
AVEM	0.01%	$3M	—
ONEQ	0.02%	$2M

Public attention · ONC

Is the crowd watching?

38/ 100 · vs its own 90-day norm▲ 24 vs 7dStealth leader

Strong relative strength, but attention is quiet relative to this name’s own recent norm. Academic work links low public attention to better forward returns on average — context to weigh, not a forecast.

Measures how unusual this name’s public attention is against its own 90-day history — a surprise reading, not a ranking of how watched it is versus other stocks. Intel, not a signal.

News

BeOne Medicines (ONC) Stock May Be Rich After BRUKINSA Access Renewal - simplywall.st · simplywall.st

Reference

Company snapshot

SectorHealthcare

IndustryPharmaceutical Products

SIC2834

Floatn/a

Shares out113.1Mshares

Market cap$42.1BLarge Cap

FAQ

Frequently asked questions

What is ONC's relative strength rating?: ONC ranks at the 78th percentile over 1 month, 81th percentile over 3 months, 47th percentile over 6 months, 61th percentile over 1 year against the full TickerStance CS+ADRC universe of U.S. equities.
What sector is ONC in?: ONC is classified under the Healthcare sector within the Pharmaceutical Products industry per the TickerStance sector-classification pipeline, which maps U.S. equities to GICS-aligned sectors using exchange SIC codes and Massive Finance reference data. Healthcare is currently ranked 3 of 11 sectors by relative strength.
Is ONC in a leading sector?: Yes — Healthcare ranks at the 82th percentile by sector relative strength, placing it in the leading band (≥ 70th percentile). ONC benefits from positive sector-level momentum, which historically correlates with above-average stock-level RS performance in the O'Neil / Minervini framework.
How volatile is ONC?: ONC currently shows a 20-day average daily range (ADR%) of 2.3%, a 90-day beta versus the S&P 500 of 0.60. ADR% and ATR% are updated daily; beta is computed over a trailing 90-day window.
Does ONC have a seasonal pattern?: TickerStance computes ONC's month-by-month seasonality from its full daily price history: the average and median return for each calendar month, how often that month closed higher, and the best and worst months on record. These are historical frequencies, not forecasts — a strong seasonal month describes what ONC has tended to do in prior years, not a prediction of what comes next. The full month-by-month heatmap and win-rate table sit higher on this page.

APPEARS IN

Featured in these lists

1 list

ADR Tight

BeOne Medicines Ltd. American Depositary Shares (ONC) — Stance & relative strength

Lenses lit

Market backdrop

§ Seasonality

Receipts behind the read

Is it leading?

Who's accumulating?

Does the business back the chart?

Is earnings accelerating?

Sector context

Who else is leading?

Healthcare · 3 of 11

Same industry, closest relative strength

ETFs holding ONC

Is the crowd watching?

Company snapshot

Frequently asked questions

Featured in these lists

How much does it move?

Is revenue confirming?

Are margins expanding?

Share count: tailwind or headwind?

§ Seasonality

BeOne Medicines Ltd. American Depositary Shares (ONC) — Stance & relative strength

ONC is on the watchlist, not confirmed. 3m RS is 81, Market Stance is mixed at 47.8, A/D rating A

Lenses lit

Market backdrop

Receipts behind the read

Is it leading?

Who's accumulating?

Does the business back the chart?

Is earnings accelerating?

Sector context

Who else is leading?

Healthcare · 3 of 11

Same industry, closest relative strength

ETFs holding ONC

Is the crowd watching?

Company snapshot

Frequently asked questions

Featured in these lists

How much does it move?

Is revenue confirming?

Are margins expanding?

Share count: tailwind or headwind?